Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Histone Deacetylase Inhibitor (HDACi)
100%
AKT/mammalian Target of Rapamycin
100%
Carcinoma Cells
100%
Mammalian Target of Rapamycin Signaling
100%
Gallbladder Cancer
100%
Suberoylanilide Hydroxamic Acid
83%
Trichostatin A
83%
Cell Viability
33%
Mammalian Target of Rapamycin (mTOR)
33%
Flow Cytometry
16%
Microscopy
16%
Cell Proliferation
16%
Apoptosis
16%
Induced Apoptosis
16%
Malignancy
16%
C-Myc
16%
Western Blotting
16%
P70S6K
16%
MTOR Inhibitor
16%
Akt Phosphorylation
16%
4E-BP1
16%
BMI1
16%
Cyclin D1 (CCND1)
16%
High Mortality
16%
Phosphorylation
16%
Cell Apoptosis
16%
Rapamycin
16%
Phosphate
16%
Acid Treatment
16%
Cell Morphology
16%
Proliferation Apoptosis
16%
G1 Phase
16%
MTT Assay
16%
Curative Resection
16%
Apoptotic Cells
16%
Mammalian Target of Rapamycin Signaling Pathway
16%
Cell Cycle Distribution
16%
Acid-promoted
16%
Pharmacology, Toxicology and Pharmaceutical Science
Mammalian Target of Rapamycin
100%
Histone Deacetylase Inhibitor
100%
Protein Kinase B
100%
Gallbladder Carcinoma
100%
Vorinostat
71%
Trichostatin A
71%
Cell Viability
28%
Western Blot
14%
Mammalian Target of Rapamycin Inhibitor
14%
Flow Cytometry
14%
Rapamycin
14%
Cyclin D1
14%
Glycerophosphate
14%